Lung Cancers Withdrawn Phase 2 Trials for Afatinib (DB08916)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01480141A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC)Treatment